baber/WOPTO huggingface dataset:
Patent JP-3530777-B2 (JP)
IPC: B65C9/22
Filed: 1999-07-28
Granted: 2004-05-24
Abstract: The present invention provides an adhesion method for bonding a label to a container, in which initial adhesion is excellent and at least one mechanical compatibility selected from an application pattern on the label, easy control of a scraper, and prolongation of the scraper life is improved. An adhesion method for bonding a label to a container is provided, in which an aqueous adhesive for the label which comprises (A) casein and (B) thixotropy index regulator and has a thixotropy index (TI) of 0.5 to 0.8 is used. At least one resin selected from polyvinyl acetate, ethylene-vinyl acetate copolymer, and acrylic resin, and wheat protein, soybean protein, denatured soybean protein, and starch are preferable as (B). The adhesion method is particularly suitable in a pallet transfer rotary labeler such as labeler manufactured by Krones Co., Ltd. Since the conventionally used suitable space, with which troubles hardly occur, is used as the space of the scraper, it is possible to bond the label to the container at a high speed.
Patent JP-3199062-B2 (JP)
IPC: G03G15/02
Filed: 1999-07-28
Granted: 2001-08-13
Abstract: An engine controller (12) adjusts an image density of the toner image to a target density by controlling an electrifying bias and a development bias. The engine controller (12) determines an optimal development bias which is needed to obtain the target density based on densities of first patch images which are formed in the following bias condition: The electrifying bias is fixed at the most recent optimal electrifying bias which is stored in a RAM; and the development bias is gradually changing based on the most recent optimal development bias which is stored in the RAM.  <IMAGE>
Patent JP-4510180-B2 (JP)
IPC: A01N31/16
Filed: 1999-07-29
Granted: 2010-07-21
Abstract: Sanitization of virus-contaminated tissues, cell cultures, blood, plasma, blood or plasma fractions and materials and equipment used in virology comprising using a solution of a phenol or phenyl ether (I) with one or two saturated or unsaturated hydrocarbon substituents, each containing up to 4 carbon atoms, is new.  An Independent claim is also included for a composition for sanitizing tissues or cell cultures or materials and equipment used in virology, comprising a solution of (I).
Patent JP-H0645756-B2 (JP)
IPC: C08L83/04
Filed: 1989-08-29
Abstract: The present invention relates to an aqueous silicone dispersion which crosslinks to give an elastomer by elimination of water and which comprises: 100 parts of an emulsion (A) of the oil-in-water type, of an  alpha , omega -(dihydroxy)polydiorganosiloxane stabilised with an anionic and/or nonionic surfactant, 1 to 100 parts of a hydroxylic silicone resin which, per molecule, exhibits at least 2 different units chosen from among those of the formulae R3SiO0.5, R2SiO, RSiO1.5 and SiO2 and having a content of hydroxyl groups of between 0.1 and 10% by weight, 0 to 250 parts of a non-siliceous inorganic filler and 0.01 to 3 parts of a metal compound which acts as a hardening catalyst, the said emulsion having a pH which is generally between 4 and 13 and a solids content of at least 40%. Use of the emulsions for the production of silicone elastomer joints, especially in the building industry.
Patent JP-H0743682-B2 (JP)
IPC: G06F13/00
Filed: 1991-04-12
Abstract: A workstation or server having a central processing unit (CPU) and a standard system bus interface and loopback control logic. The I/O subsystem is tested through the application of diagnositc programs running in the CPU which use programmed I/O bus cycles to read and write from the standard system bus interface. In this way, the CPU, with the loopback test mode enabled, can functionally test data paths and controls utilized to perform programmed I/O accesses to the standard system bus interface without having to access an external system bus device. Furthermore, a loopback bus cycle can cause a direct virtual memory access (DVMA) bus cycle to be created at the system bus interface. Therefore, the CPU, with the loopback test mode enabled, can also functionally test data paths and controls utilized to perform system memory DVMA without the presence of an external system bus device.
Patent JP-2859105-B2 (JP)
IPC: A61K47/48
Filed: 1993-08-23
Granted: 1999-02-17
Abstract: The present invention relates to physiologically active water soluble polyethylene glycol conjugates with interferon and to new polyethylene glycol compounds which can be used in the preparation of the conjugates.
Patent JP-2593886-B2 (JP)
IPC: A01N25/04
Filed: 1987-09-16
Granted: 1997-03-26
Abstract: Plant protection agents containing one or more agents, based on suspoemulsions containing aqueous and organic phases, the organic phase containing one or more surfactants from the group of ethylene oxide/propylene oxide block polymers having an average molecular weight of 1000 - 20000. The suspoemulsions are exposed to high shear forces. Even afterwards, they exhibit constant viscosity behaviour, despite a larger drop number and smaller drop size.
Patent JP-2620333-B2 (JP)
IPC: A61K31/565
Filed: 1988-09-28
Granted: 1997-06-11
Abstract: Agents, containing at least one compound having antiprogestational activity and at least one compound having anti-estrogenic activity, are suitable for the treatment of hormone-dependent tumors.
Patent JP-3429984-B2 (JP)
IPC: B60W30/00
Filed: 1997-09-16
Granted: 2003-07-28
Abstract: PROBLEM TO BE SOLVED: To make quick conversion of the car speed to a new target value using the coast-down system regardless of the switch operation time in the coast-down operation. SOLUTION: When a coast-down command signal lasts for a period longer than the predetermined time A, the initialize valve I obtained by an initialize calculating means is compared with the set initialize value Iset obtained by a set initialize calculating means, and if the obtained initialize value I is below the set initialize value Iset, the initialize value I is emitted as the output of coast-down initialize, and if I is greater than Iset, the Iset value is emitted as the output of coast-down initialize so as to drive an actuator in the accelerative direction. When the coast-down command signal goes out within a short time before the predetermined time is filled, the output of coast-down initialize Icd is stopped.
Patent JP-H0814776-B2 (JP)
IPC: G05F3/22
Filed: 1987-10-26
Abstract: A bias generator for use in CML gate circuits provides an output reference voltage that is substantially independent of variations in supply voltage over a wide temperature range. The bias generator includes a temperature and voltage compensating circuit portion which is formed of an emitter resistor and a diode-connected transistor. The emitter resistor is used to control the output reference voltage for the lower temperatures and the base-emitter voltage of the transistor determines the output reference voltage for the higher temperatures.
Patent JP-2566429-B2 (JP)
IPC: G01N1/28
Filed: 1987-11-27
Granted: 1996-12-25
Abstract: Tissue specimen treatment apparatus of the multi-chamber type having a plurality of chambers (22), for instance arranged in a circle, and means for transporting a specimen for treatment to selected such chambers in a prescribed sequence, is characterised by a containment vessel (20, 24) for at least the (open) upper ends of the chambers and by cover means (26) movable with and enclosing the transporting means while separating the interior of the containment vessel from the ambient atmosphere. The cover means (26) preferably closely overlies the tops of the chambers (22) to minimise the volume of the containment vessel, and is formed with a small volume transfer enclosure (32) to receive a specimen during transport. The cover (26) may have a close fit to the containment vessel, sufficient to restrict exchange of gases etc. between the external atmosphere and the containment vessel, or more positive sealing arrangements may be provided - e.g. labyrinth, flexible or liquid seals - to prevent flows between the vessel and the environment. Additionally or alternatively, positive venting of the containment vessel by withdrawl of its atmosphere may ensure that all leakages are into the vessel.
Patent JP-H07106225-B2 (JP)
IPC: A61N1/32
Filed: 1991-11-01
Abstract: A method and apparatus for applying iontophoretic treatment to a biological subject wherein electrical treatment current between a pair of electrodes is periodically reversed at very low frequencies, substantially in the range of approximately 0.0027 Hz to approximately 10 Hz, to mitigate tissue damage, enable long term dosimetry with single and multiple drugs of any polarity and at higher concentrations, and eliminate the need for buffering agents and the like, all in a relatively simple, economical and compact physical packaging configuration. The system delivers treatment substances with large and/or small molecular size and weight and can be adjusted to control pH at the delivery site. A method of lowering resistance and enhancing permeability at the delivery site, as well as increasing drug concentrations and delivery rates. <IMAGE>
Patent JP-3248685-B2 (JP)
Title: Dust removing head
Inventor: UZAWA HIROSHI
IPC: B01D46/42
Filed: 1998-11-06
Granted: 2002-01-21
Abstract: PROBLEM TO BE SOLVED: To simplify the structure of the dust eliminator and to set it even in a small space in the dust eliminator for removing dust depositing on a large- sized sheet. SOLUTION: This dust eliminator is provided with a couple of dust collecting heads 2. The head 2 has a dust suction port 3 on the upstream side, a dust suction port 4 on the downstream side and an injection nozzle 5 furnished between the suction port 3 and the suction port 4 and injecting an ultrasonic air E. The couple of dust collecting heads 2 are provided on both face sides of a large-sized sheet 1 so that the suction ports 3 and 4 are symmetrical about the nozzles 5. The nozzles 5 are inclined to the downstream side in respect to the sheet 1 when seen from the side.
Patent JP-3310249-B2 (JP)
IPC: B01D53/04
Filed: 1999-11-24
Granted: 2002-08-05
Abstract: A gas mixture, especially air, is separated by a pressure swing adsorption process in which a portion of adsorber effluent gas is stored (31) and recycled (29, 27, 25, 23) to the adsorber (21) countercurrently to, and simultaneously with, an evacuation of gas therefrom. The product gas recycle is recycled (i) after depressurization with continued evacuation of gas such that the pressure in the adsorber vessel (21) remains essentially constant at a minimum adsorber pressure and/or (ii) during at least a part of repressurization in a combined repressurization-purge step such that the pressure in the adsorber vessel (21) increases to a value intermediate the minimum adsorber pressure and the feed pressure and/or (iii) during at least a part of depressurization of the adsorber vessel (21). The recycle shortens cycle time and improves overall system operation. <IMAGE>
Patent JP-2935137-B2 (JP)
IPC: A61K31/445
Filed: 1989-11-20
Granted: 1999-08-16
Abstract: PCT No. PCT/FR89/00596 Sec. 371 Date Jun. 21, 1990 Sec. 102(e) Date Jun. 21, 1990 PCT Filed Nov. 20, 1989 PCT Pub. No. WO90/05524 PCT Pub. Date May 31, 1990.The invention relates to pharmaceutical compositions for neuroprotection containing arylcyclohexylamines. These compositions comprise an arylcyclohexylamine in accordance with the formulas:   <IMAGE> (I)  <IMAGE> (II)  in which: R1 represents <IMAGE>   with R4 being a hydrogen atom, a fluorine atom, an iodine atom or a methyl radical, R2 stands for a hydrogen atom, the radical OH or the radical CH3 and R3 stands for hydrogen atom or the radical CH2R5 with R5 representing H, OH, Cl, Br or CH3COO, provided that R2 and R3 are not both a hydrogen atom, or an addition salt to a pharmaceutically acceptable acid of said arylcyclohexylamine.
Patent JP-H0723764-B2 (JP)
IPC: F23C10/10
Filed: 1988-04-20
Abstract: A fluidized bed reactor has a pair of cyclone separators which receive flue gas with entrained solids and wherein the solids are separated from the flue gas in the separators for flow into a fluidized distribution conduit. The flow of separated particles is divided into two particle streams and fluidizing air is introduced into the duct. The fluidized separated particles are then conveyed to the combustion chamber of the reactor through an upright conduit in turn connected to a downwardly inclined conduit connecting the combustion chamber with the fluidized separated particles in the duct. The downwardly inclined conduits are substantially equidistantly distributed along the lateral extent of the combustion chamber to provide even distribution of the solid separated particles with fuel mixed therein in the combustion chamber.
Patent JP-3018046-B2 (JP)
IPC: A61P35/00
Filed: 1991-02-06
Granted: 2000-03-13
Abstract: An agent for inhibiting the growth of tumor cells, comprising a dextran derivative consisting of a polysaccharide chain substituted with carboxymethyl and carboxymethylbenzylamide sulphonate groups, said derivative being designated by general formula (DX?CMY?BSZ?), wherein X represents the average number of unsubstituted saccharide units per 100 saccharide units, Y represents the average number of carboxymethyl groups per 100 saccharide units, and Z represents the average number of carboxymethylbenzylamide sulphonate groups per 100 saccharide units. Said agent is characterized in that X is equal to or lower than 50, Y is between 10 and 90, and Z is between 15 and 35.
Patent JP-3868484-B2 (JP)
IPC: A01N47/40
Filed: 1995-07-17
Granted: 2007-01-17
Abstract: A mixt. contg. (a) a heteroaralkyl amine deriv. of formula R-N(A)-C(Z)=X-E (I); and (b) a fungicide (II) other than a cyclopropylcarboxamide deriv. or an azoylmethylcycloalkane, is claimed. X = =CH- or =N-; E = electron withdrawing gp.; R = opt. substd. heteroaralkyl; A = H or alkyl; and Z = alkyl; alkylamino or dialkylamino; or A and Z are linked by a bifunctional gp. The mixt. may also contain other active agents as well as adjuvants, additives and diluents. (I) are known from EP 192060. (II) are known from DE 2201063, DE 2324010, DE 2737489, DE 3018866, DE 2551560, EP 47594, DE 2735862, EP 68813, US 4496551, DE 2429523, DE 2856975, US 4108411, DL 140041, EP 382375, EP 515901, EP 314422, EP 49854, DE 1770288, US 3869456, DE 2207576, US 3903090, US 3755350, US 3823240, EP 270111, EP 219756, US 4512989, EP 398682, EP 281842 and "Pflanzenschutz und Schadlingsbekampfung", pp 121-153, published by Georg Thieme, Stuttgart, 1977.
Patent JP-2763562-B2 (JP)
IPC: A61K31/19
Filed: 1988-07-08
Granted: 1998-06-11
Abstract: Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
Patent JP-3162401-B2 (JP)
IPC: C08L83/12
Filed: 1994-07-19
Granted: 2001-04-25
Abstract: Provided hair styling compositions comprising: (a) from about 0.1% to about 15%, by weight, of a silicone grafted adhesive polymer, said polymer being characterized by an organic polymeric backbone having silicone macromers grafted to said backbone; (b) from about 0.5% to about 15%, by weight, of a hydrocarbon solvent selected from the group consisting of C10-C14 branched chain hydrocarbons, and mixtures thereof; (c) a polar solvent phase comprising from about 80% to about 98.9%, by weight of the composition, of a polar solvent selected from the group consisting of water and C2-C3 monohydric alcohols, and mixtures thereof, wherein said composition contains no more than about 15%, by weight, of C3 monohydric alcohol; wherein said organic polymer backbone is soluble in said polar solvent phase, and said silicone macromers of said hair setting polymer are soluble in said hydrocarbon solvent and insoluble in said polar solvent. In preferred embodiments, the compositions hereof additionally comprise a plasticizer for the silicone grafted hair setting polymer. Especially preferred plasticizers include acetyl tri-C2-C8 alkyl citrates, particularly acetyl triethyl citrate.
Patent JP-H07116155-B2 (JP)
Inventor: BANTICK JOHN RAYMOND
IPC: C07D311/92
Filed: 1990-05-17
Abstract: There are disclosed compounds of the formula (I): , R4, R5, R6, and X are defined in the specification. The compounds are useful as pharmaceuticals, especially as anti-inflammatory agents.
Patent JP-3423720-B2 (JP)
IPC: C12N5/10
Filed: 1994-09-19
Granted: 2003-07-07
Abstract: A method of assaying collagen fragments in body fluids, including bringing a sample of body fluid in contact with at least one immunological binding partner for the collagen fragments, said binding partner being immunoreactive with synthetic peptides, the sequences of which are essentially derived from collagen and containing potential sites for cross-linking. The immunological binding partners are incorporated, either as whole antibodies or as immunologically active fragments thereof, in an assay for quantitative determination of collagen fragments in the sample. In addition to being contacted with the immunological binding partner(s), the sample may be brought into direct contact with the corresponding synthetic peptide. The invention further comprises a test kit and specific means for carrying out the method. The structure of specific peptides is also described.
Patent JP-H0817787-B2 (JP)
IPC: A61F2/30
Filed: 1992-03-19
Abstract: A beam adapted for implantation within a bone is able to support bending and torsional loading forces applied thereto. The beam has a stiffness defined by a modulus elasticity, which stiffness varies along the length of the beam to match the corresponding stiffness of the cortical bone adjacent the beam after implantation within the bone. The beam is made from an elongated core formed of continuous filament carbon fibers embedded in a thermoplastic polymer matrix with the carbon filaments extending in a direction substantially parallel to the longitudinal axis of the beam. Encasing the core is a filler molded to the core, which filler is made up of the same thermoplastic polymer as the core but contains no reinforcing carbon fibers. The filler provides the prosthesis with a shape generally conforming to the desired shape of the final prosthetic implant. A sheath formed of carbon reinforced filament fibers embedded in the thermoplastic polymer is wound in spiral formation around the filler and molded thereto. The winding angle and the sheath thickness along the beam may be varied to vary the modulus of elasticity to match that of the cortical bone adjacent thereto.
Patent JP-2815120-B2 (JP)
IPC: G01N33/553
Filed: 1989-11-09
Granted: 1998-10-27
Abstract: A matrix coating suitable for use in a biosensor is provided. This matrix coating comprises a hydrogel bound to a surface and via which a desired ligand can be bound. This hydrogel is activated to contain charged groups for bringing about the concentration of biomolecules carrying an opposite charge to that of said charged groups, and reactive groups for covalently binding the biomolecules concentrated to the matrix coating.
Patent JP-4153991-B2 (JP)
IPC: F16H39/10
Filed: 1995-10-10
Granted: 2008-09-24
Abstract: A continuously variable hydrostatic transmission includes an input shaft connected to drive a hydraulic pump unit, a grounded hydraulic motor unit, and an output shaft. A wedge-shaped swashplate is pivotally mounted to the output shaft in driving connection to receive output torque resulting from the exchange of pressurized hydraulic fluid between the pump and motor units through specially configured ports in the swashplate. A hydraulically actuated ratio controller is pivotally linked to the swashplate to selectively adjust the swashplate angle relative to the output shaft axis and thereby change transmission ratio.
Patent JP-2975957-B2 (JP)
IPC: G01C5/06
Filed: 1991-09-26
Granted: 1999-11-10
Abstract: An accumulating altimeter includes a programmable accumulator which selectively accumulates altitude changes from a reference altitude in accordance with accumulation thresholds. Altitude changes in the direction of interest, e.g. altitude gains, are accumulated once a non-opposing accumulation threshold has been reached. Opposing altitude changes which are less than an opposing accumulation threshold are used to offset non-opposing changes. Opposing altitude changes which are equal to or greater than the opposing accumulation threshold are used to re-establish the reference altitude, whereafter accumulation of non-opposing altitude changes resume after the non-opposing accumulation threshold has been reached.
Patent JP-3725557-B2 (JP)
IPC: A61K36/00
Filed: 1997-10-07
Granted: 2005-12-14
Abstract: The present invention relates to novel pharmaceutical and cosmetic formulations with antiacne activity containing: a) an antimicrobial hydrophilic extract of Krameria sp., or a pure compound from said extract and/or an antimicrobial lipophilic extract of Mesua ferrea; b) ximeninic acid and/or lauric acid; c) anti-inflammatory saponins extracted from Olax dissitiflora, Aesculum hippocastanum, Centella asiatica, Terminalia sericea, Glycyrrhiza glabra.
Patent JP-3061641-B2 (JP)
IPC: B22D11/07
Filed: 1996-03-11
Granted: 2000-07-10
Abstract: PCT No. PCT/DE96/00460 Sec. 371 Date Oct. 17, 1997 Sec. 102(e) Date Oct. 17, 1997 PCT Filed Mar. 11, 1996 PCT Pub. No. WO96/29164 PCT Pub. Date Sep. 26, 1996Disclosed is a method and apparatus for a metal melt, especially steel, into a vertically oscillating mold via a tundish or intermediate vessel provided with an immersion nozzle to generate endless strands, especially thin strands of steel wherein the intermediate vessel has an open first chamber and a closed second chamber. The metal melt is supplied from the casting ladle to the first open chamber. The second chamber is connected with a vacuum device. An immersion pipe, which projects into the mold and which can be vertically oscillated, is provided in the base of the second chamber.
Patent JP-4271260-B2 (JP)
IPC: C12N15/88
Filed: 1997-02-28
Granted: 2009-06-03
Abstract: Amidino-substituted carbamates of formula R2R3N-COOR1 (I) and their salts are new. R1 = cholesterol derivative or NR'R''; R', R'' = 12-22C optionally unsaturated, branched or linear aliphatic group (sic); R2, R3 = H (not both of them) or [(CH2)nNR4]mR5 (II); n, m = 0-4; R4, R5 = H or (CH2)pXr[(CH2)q-C(NH2)=NH2+]x (III); p, q = 0-4; r = 0 or 1; when r = 1, X = NH and x = 1, or X = N and x = 2.
Patent JP-3653569-B2 (JP)
IPC: H04N7/173
Filed: 1998-01-30
Granted: 2005-05-25
Abstract: A method for displaying streamed digital video data on a client computer. The client computer is configured to receive the streamed digital video data from a server computer via a computer network. The streamed digital video data is transmitted from the server computer to the client computer as a stream of video frames. The method includes receiving a first plurality of video frames at the client computer. The plurality of video frames represents a subset of the stream of video frames. The stream of video frames comprises independent playable video frames and dependent playable video frames. The method further includes displaying the first plurality of video frames on a video display terminal associated with the client computer. There is further included issuing a rewind command from the client computer to the server. The rewind command causes a second plurality of video frames of the stream of video frames different from the first plurality of video frames to be streamed from the server computer to the client computer. The second plurality of video frames has been streamed at least once to the client computer.